Peter Van Vlasselaer
Peter Van Vlasselaer publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Immunotherapy and Immune Responses.
- World rank
- #2,049,143 of 7,710,434 ranked researchers
- Rank in United States
- #620,338 of 1,627,098
- Works
- 64
- Citations
- 2.9k
- Citations per work
- 45.5
What does Peter Van Vlasselaer research?
Peter Van Vlasselaer's work is mostly in Medicine (37%), Immunology and Microbiology (25%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2436.9%
- Medicine2436.9%
- Life Sciences2234.8%
- Everything else1828.3%
- 1Oncology32% of their works
- 2Immunology25% of their works
- 3Molecular Biology6% of their works
- 4Biotechnology4% of their works
- 5Pulmonary and Respiratory Medicine3% of their works
- 6Radiology, Nuclear Medicine and Imaging3% of their works
Research topics
Which keywords describe Peter Van Vlasselaer's research?
The keywords of their largest research topics: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Immune Checkpoint Blockade, PD-1 and PD-L1, CAR T Cells, Chimeric Antigen Receptor and Dendritic Cells.
- Renal Cell Carcinoma
- Foxp3
- Bacterial Therapy
- Natural Killer Cells
- Decidual NK Cells
- Dendritic Cells
- CAR T Cells
- Immune Checkpoint Blockade
- Immunotherapy
- Cancer Immunotherapy
- Tumor Regression
- PD-1 and PD-L1
- Chimeric Antigen Receptor
- Immunity
- NK Cell Recognition
- Regulatory T Cells
- Tumor Targeting
- Metastatic
- TGF-ß
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cancer Immunotherapy352 topics
- Immunotherapy303 topics
- Tumor Regression252 topics
- Immune Checkpoint Blockade241 topic
- PD-1 and PD-L1241 topic
- CAR T Cells191 topic
- Chimeric Antigen Receptor191 topic
- Dendritic Cells161 topic
- Immunity161 topic
- Decidual NK Cells71 topic
- NK Cell Recognition71 topic
- Natural Killer Cells71 topic
- Regulatory T Cells71 topic
- Bacterial Therapy61 topic
- Tumor Targeting61 topic
- Foxp351 topic
- Metastatic51 topic
- Renal Cell Carcinoma51 topic
- TGF-ß51 topic
Where does Peter Van Vlasselaer work?
Peter Van Vlasselaer's main affiliation in the publication record is Coherus BioSciences (United States), United States.
How many publications and citations does Peter Van Vlasselaer have?
OpenAlex counts 64 works and 2,914 citations for Peter Van Vlasselaer, an h-index of 18, ranking #2,049,143 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Peter Van Vlasselaer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.